Logo image of TEAF

TORTOISE SUST&SOCIAL IMP TER (TEAF) Stock Price, Quote, News and Overview

NYSE:TEAF - New York Stock Exchange, Inc. - US27901F1093 - Currency: USD

12.2  +0.01 (+0.12%)

After market: 12.15 -0.05 (-0.41%)

Fundamental Rating

2

TEAF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of TEAF is average, but there are quite some concerns on its profitability. TEAF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TEAF has reported negative net income.
In the past year TEAF had a positive cash flow from operations.
In multiple years TEAF reported negative net income over the last 5 years.
TEAF had a positive operating cash flow in 4 of the past 5 years.
TEAF Yearly Net Income VS EBIT VS OCF VS FCFTEAF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

The 3 year average ROIC (2.28%) for TEAF is below the current ROIC(2.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.65%
ROE -2.98%
ROIC 2.42%
ROA(3y)0.53%
ROA(5y)-0.75%
ROE(3y)0.6%
ROE(5y)-0.86%
ROIC(3y)2.28%
ROIC(5y)2.09%
TEAF Yearly ROA, ROE, ROICTEAF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 2 -2 -4 -6 -8

1.3 Margins

TEAF's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of TEAF has remained more or less at the same level.
Industry RankSector Rank
OM 63.88%
PM (TTM) N/A
GM 67.14%
OM growth 3Y-0.91%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.31%
GM growth 5YN/A
TEAF Yearly Profit, Operating, Gross MarginsTEAF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, TEAF has about the same amount of shares outstanding.
The debt/assets ratio for TEAF has been reduced compared to a year ago.
TEAF Yearly Shares OutstandingTEAF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
TEAF Yearly Total Debt VS Total AssetsTEAF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

TEAF has an Altman-Z score of 3.92. This indicates that TEAF is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of TEAF is 1.20, which is an excellent value as it means it would take TEAF, only 1.20 years of fcf income to pay off all of its debts.
TEAF has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Although TEAF does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.2
Altman-Z 3.92
ROIC/WACCN/A
WACCN/A
TEAF Yearly LT Debt VS Equity VS FCFTEAF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 2.41 indicates that TEAF has no problem at all paying its short term obligations.
A Quick Ratio of 2.41 indicates that TEAF has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.41
TEAF Yearly Current Assets VS Current LiabilitesTEAF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M

0

3. Growth

3.1 Past

TEAF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -263.89%.
Looking at the last year, TEAF shows a decrease in Revenue. The Revenue has decreased by -0.98% in the last year.
Measured over the past years, TEAF shows a decrease in Revenue. The Revenue has been decreasing by -2.97% on average per year.
EPS 1Y (TTM)-263.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-347.17%
Revenue 1Y (TTM)-0.98%
Revenue growth 3Y-2.97%
Revenue growth 5YN/A
Sales Q2Q%-1.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TEAF Yearly Revenue VS EstimatesTEAF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
TEAF Yearly EPS VS EstimatesTEAF Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TEAF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TEAF Price Earnings VS Forward Price EarningsTEAF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 8.2
EV/EBITDA N/A
TEAF Per share dataTEAF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

TEAF has a Yearly Dividend Yield of 8.16%, which is a nice return.
TEAF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 8.16%

5.2 History

TEAF has been paying a dividend for over 5 years, so it has already some track record.
TEAF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years3
TEAF Yearly Dividends per shareTEAF Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of TEAF are negative and hence is the payout ratio. TEAF will probably not be able to sustain this dividend level.
DP-244.06%
EPS Next 2YN/A
EPS Next 3YN/A
TEAF Yearly Income VS Free CF VS DividendTEAF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 -100M -200M

TORTOISE SUST&SOCIAL IMP TER

NYSE:TEAF (2/11/2025, 8:04:00 PM)

After market: 12.15 -0.05 (-0.41%)

12.2

+0.01 (+0.12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.02%
Inst Owner Change-72.78%
Ins Owners0.12%
Ins Owner Change0%
Market Cap164.58M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 8.16%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-244.06%
Div Incr Years2
Div Non Decr Years3
Ex-Date02-21 2025-02-21 (0.09)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.32
P/FCF 8.2
P/OCF 8.2
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.49
FCFY12.2%
OCF(TTM)1.49
OCFY12.2%
SpS0.8
BVpS14.84
TBVpS14.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.65%
ROE -2.98%
ROCE 3.06%
ROIC 2.42%
ROICexc 2.42%
ROICexgc 2.42%
OM 63.88%
PM (TTM) N/A
GM 67.14%
FCFM 186.88%
ROA(3y)0.53%
ROA(5y)-0.75%
ROE(3y)0.6%
ROE(5y)-0.86%
ROIC(3y)2.28%
ROIC(5y)2.09%
ROICexc(3y)2.28%
ROICexc(5y)2.09%
ROICexgc(3y)2.28%
ROICexgc(5y)2.09%
ROCE(3y)2.89%
ROCE(5y)2.65%
ROICexcg growth 3Y-0.93%
ROICexcg growth 5YN/A
ROICexc growth 3Y-0.93%
ROICexc growth 5YN/A
OM growth 3Y-0.91%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.31%
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.2
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage -3.91
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 2.41
Altman-Z 3.92
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-263.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-347.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.98%
Revenue growth 3Y-2.97%
Revenue growth 5YN/A
Sales Q2Q%-1.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.61%
EBIT growth 3Y-3.85%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.41%
FCF growth 3Y8.75%
FCF growth 5YN/A
OCF growth 1Y115.41%
OCF growth 3Y8.75%
OCF growth 5YN/A